Development of Targeted Therapies for 3q26-positive MDS
Original Research Center:
University of Rochester
Current Position/Title:
Professor - Department of Pathology and Laboratory Medicine (SMD)
2009
Current Institution:
University of Rochester
Dr. Perkins is an active participant in the clinical hematopathology service as well as a researcher exploring the genes that impact the development of leukemias and other human malignancies. His primary focus is acute myeloid leukemia (AML), a particularly lethal type of cancer with no effective thereapies at present. His clinical responsibilities include interpretation of bone marrow biopsies and smears, lymph node biopsies, and spleen; and laboratory analyses of coagulation disorders and hemoglobinopathies.